🔐 Deeptech Signals Premium: Why I’m All-In on AI Biotech (And Where I’d Put $1M Right Now)
Your Weekly Shortcut to Deeptech Investing — Trends, Startup Intel & Investor Playbooks for VCs & Angels in 5 Minutes or Less
High-signal startup breakdowns, IP trends, and strategy—built for smart-driven capital.
Hi investors, it’s Thursday, and today I’m bringing you the good stuff to the exciting world of AI biotech. The U.S. government is pouring $500 million in 2025 to help new companies make medicine faster and better—like the COVID vaccines that worked so well. Plus, smart people at Harvard and MIT are finding new ways to speed things up even more. There’s also a company called Orakl Bio that just got $75 million from Samsung. They’re using computers to create new kinds of medicine.
I’ve got some tools to help you too: my Red Flag Filter to spot bad investments and an Investment Checklist to find the good ones. Why should you care? Because AI biotech could turn a $1 million investment into $5 million by 2030.
Want to check this out together? This is your insider track to 10x returns.
Let’s get to it. 👇
1️⃣
🚨 The Macro Trigger I’m Watching This Week: AI Biotech’s Big Funding Surge
AI biotech is exploding, and it’s a global race you can’t ignore. The U.S. just pumped $500 million more into AI-driven biotech this year via the NIH and DARPA (NIH Budget, March 2025), targeting game-changers like RNA vaccines and antibodies. Europe’s flexing too, with $8.5 billion poured into biotech startups in 2024 (Boston Consulting Group, 2024). AI’s slashing drug development timelines from years to weeks, and the stakes are sky-high—a $1 million investment today could balloon to $5 million by 2030.
2️⃣
🔬I’m Tracking a Game-Changing Patent Signal—Your Biotech Goldmine Starts Here!
The labs are buzzing with breakthroughs that could redefine drug discovery—and your portfolio. In January 2025, Harvard and MIT dropped five game-changing patents on protein design algorithms and RNA folding simulations (USPTO, March 2025). These aren’t just incremental tweaks—they’re AI-powered tools that could slash drug development time by 70% and cut costs from $2.6 billion to $500 million per drug (Forbes, March 2025). For you, it’s a flashing neon sign: startups leveraging this tech could be your next 5-10x win.
3️⃣
💥I’m Breaking Down Orakl Bio—Samsung’s Bold AI x RNA Power Play You Can’t Ignore
Let’s talk about Orakl Bio, a stealth-mode startup that’s stepping into the spotlight. Launched in Q1 2025 with $75 million in funding, Orakl is co-founded by Samsung and backed by SBV (Samsung’s biotech investment arm), alongside strategic investors from Korea and Europe. Their big idea? Using AI to turbocharge RNA therapeutics—think next-level drug design that could redefine medicine. With a stellar team, cutting-edge tech, and Samsung’s muscle behind them, Orakl’s got serious potential. But there are risks to weigh.
4️⃣
🔥 I’m Revealing the Secrets to Investing in AI-Biotech Startups: Find the Winners, Skip the Failures!
AI-biotech startups are revolutionizing healthcare by merging artificial intelligence with biotechnology, creating opportunities for massive returns—but also massive risks. With 90% of these ventures failing (Nature Biotech, 2024), investing here is like navigating a treasure map through a jungle: thrilling, yet perilous. This guide equips you with everything you need to protect your capital and pinpoint the goldmines. Packed with specific opportunities, risk breakdowns, exit strategies, case studies, and a global outlook, it’s your playbook to build a winning portfolio.
5️⃣
🔍 I’m Unveiling the $1B AI Biotech Investor Playbook (Q2 2025) — My Exclusive Signals for Smart Capital Only
I just dropped the “Q2 2025 AI Biotech Investor Playbook” — a private deep-dive for paid members. Inside, I unpack the real signals driving the funding surge: the platforms I’m tracking across the U.S., EU, China, and Israel; the labs quietly spinning out billion-dollar IP; and the investor filters I personally use to separate conviction bets from biotech noise. If you want the full playbook and deal-ready insights, you can unlock it by upgrading to Deeptech Signals Premium.
Let’s Go Deeper
Want in? DM me at info@investdeeptech.io or send “ACCESS” on Instagram @eden_jana for clarity calls or exclusive scouting. You’re in the VIP club—let’s turn those $1M bets into $5M wins!
Stay sharp,
Eden Djanashvili
Author Invest Deeptech